---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-186218"
form_type: "8-K"
ticker: "IVVD"
cik: "0001832038"
company_name: "Invivyd, Inc."
filed_at: "2022-06-30T23:59:59+00:00"
generated_at: "2026-06-24T22:08:01.285771+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Adagio Therapeutics board member Howard Mayer resigns effective June 24, 2022

## Summary
- Howard Mayer, M.D. resigned from the board and all committees, effective June 24, 2022.
- Resignation was not due to any disagreement with the company's operations, policies, or practices.
- No replacement director was announced in the filing.

## SEC filing metadata
- accession: 0001193125-22-186218
- form_type: 8-K
- ticker: IVVD
- cik: 0001832038
- company_name: Invivyd, Inc.
- filed_at: 2022-06-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1832038/000119312522186218/0001193125-22-186218-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1832038/000119312522186218/d360034d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-186218
- JSON: https://secwatch.observer/filing/0001193125-22-186218.json
- Plain text: https://secwatch.observer/filing/0001193125-22-186218.txt

## Key facts
- Executive change
  Howard Mayer resigned as Director at Invivyd, Inc..
  - Action: resigned
  - Role: Director
  source text: On June 24, 2022, Howard Mayer, M.D. notified Adagio Therapeutics, Inc. (the “Company”) of his decision to resign from the board of directors of the Company and all committees thereof, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1832038/000119312522186218/0001193125-22-186218-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.